<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01267214</url>
  </required_header>
  <id_info>
    <org_study_id>HGN-THA-08-01</org_study_id>
    <nct_id>NCT01267214</nct_id>
  </id_info>
  <brief_title>The Efficacy and Safety of Intraarticular Sodium Hyaluronate (Hyalgan) After Proximal Tibial Osteotomy in Treatment of Knee Osteoarthritis Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>TRB Chemedica</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TRB Chemedica</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy and safety of Hyalgan after proximal
      tibial osteotomy in treatment of knee osteoarthritis patients. Normally, OA patients who were
      treated with osteotomy will not be treated with any SYSADOA after operation, even though
      their cartilage's not completely loss, so osteotomy plus HA injection should provide more
      benefit to patients than osteotomy alone.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Joint Space Width</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Global assessment</measure>
    <time_frame>12 months</time_frame>
    <description>assess by Patient and investigator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>WOMAC section A, B, C</measure>
    <time_frame>12 months</time_frame>
    <description>Pain score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rescue medicine consumption</measure>
    <time_frame>12 months</time_frame>
    <description>Diclofenac consumption</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Osteotomy plus Hyalgan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Osteotomy at Week 0 Hyalgan injection at Week 2, 3, 4, 5, 6, 24, 25, 26, 27, 28</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Osteotomy alone</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Hyaluronate (Hyalgan)</intervention_name>
    <description>1% Sodium Hyaluronate in prefilled syringe</description>
    <arm_group_label>Osteotomy plus Hyalgan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Osteotomy alone</intervention_name>
    <description>no injection</description>
    <arm_group_label>Osteotomy alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients between 35 and 65 years with primary knee OA with malalignment

          2. Mild to moderate OA of grade II or III severity on the Kellgren-Lawrence scale with
             require treatment by osteotomy

          3. Malalignment is not exceed 15 degree (+,-)

          4. Pain on walking (15 m) â‰¥ 40 mm.

          5. Range of motion &gt; 90 degree

          6. Evidence of adequate contraceptive methods in women of childbearing age

        Exclusion Criteria:

          1. Previous surgery on affected knee

          2. Previous intraarticular intervention within the last 3 months (eg. Steroid,
             anaesthetic, Sodium hyaluronate)

          3. Oral SYSADOA treatment (chondroitin, glucosamine, diacerein) within 2 months prior to
             study start

          4. Known or suspected infection of the affected joint

          5. Painful knee condition due to another cause than chondral lesions, such as Sudeck's
             atrophy, intraarticular neoplasm, pigmented villonodular synovitis, chondromatosis

          6. Poor general health or other conditions which would make regular hospital attendance
             difficult

          7. Ascertained hypersensitivity to any component used in the study (eg. Hyaluronic acid,
             diclofenac, morphine, omeprazole and paracetamol)

          8. Hypersensitivity to avian protein

          9. Ongoing or previous participation in a clinical study within the last 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Siriraj Hospital, Faculty of Medicine, Mahidol university</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2010</study_first_submitted>
  <study_first_submitted_qc>December 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2010</study_first_posted>
  <last_update_submitted>November 20, 2012</last_update_submitted>
  <last_update_submitted_qc>November 20, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

